{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T09:05:56Z","timestamp":1769504756506,"version":"3.49.0"},"reference-count":123,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.clnesp.2023.09.927","type":"journal-article","created":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T20:57:42Z","timestamp":1696107462000},"page":"186-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Keeping an eye on the nutrition: The importance of nutrition management on cardiometabolic risk factors in cirrhotic patients"],"prefix":"10.1016","volume":"58","author":[{"given":"Fereshteh","family":"Pashayee-khamene","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behzad","family":"Hatami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makan","family":"Cheraghpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2796-2413","authenticated-orcid":false,"given":"Zahra","family":"Yari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2023.09.927_bib1","first-page":"85","article-title":"The etiology, diagnosis and prevention of liver cirrhosis: part 1 of a series on liver cirrhosis","volume":"110","author":"Wiegand","year":"2013","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.clnesp.2023.09.927_bib2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00535-021-01788-x","article-title":"Evidence-based clinical practice guidelines for Liver Cirrhosis 2020","volume":"56","author":"Yoshiji","year":"2021","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s12072-017-9808-z","article-title":"New concepts on the clinical course and stratification of compensated and decompensated cirrhosis","volume":"12","author":"D'Amico","year":"2018","journal-title":"Hepatol Inter"},{"key":"10.1016\/j.clnesp.2023.09.927_bib4","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.jhep.2020.12.005","article-title":"Transition to decompensation and acute-on-chronic liver failure: role of predisposing factors and precipitating events","volume":"75","author":"Gustot","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib5","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/apt.12044","article-title":"The reversibility of cirrhosis","volume":"36","author":"Sohrabpour","year":"2012","journal-title":"Aliment Pharmacol Therapeut"},{"key":"10.1016\/j.clnesp.2023.09.927_bib6","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/hep.23478","article-title":"Now there are many (stages) where before there was one: in search of a pathophysiological classification of cirrhosis","volume":"51","author":"Garcia-Tsao","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.clnesp.2023.09.927_bib7","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2337\/dc09-0148","article-title":"Histological course of nonalcoholic fatty liver disease in Japanese patients: tight glycemic control, rather than weight reduction, ameliorates liver fibrosis","volume":"33","author":"Hamaguchi","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clnesp.2023.09.927_bib8","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1136\/gut.2009.205088","article-title":"Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years","volume":"59","author":"Wong","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.clnesp.2023.09.927_bib9","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.2174\/13816128113199990381","article-title":"Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment","volume":"19","author":"Dongiovanni","year":"2013","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.clnesp.2023.09.927_bib10","doi-asserted-by":"crossref","first-page":"8227","DOI":"10.3748\/wjg.v21.i27.8227","article-title":"Genomic medicine in gastroenterology: a new approach or a new specialty?","volume":"21","author":"Roman","year":"2015","journal-title":"World J Gastroenterol: WJG"},{"key":"10.1016\/j.clnesp.2023.09.927_bib11","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v21.i41.11552","article-title":"Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico","volume":"21","author":"Ramos-Lopez","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/cld.807","article-title":"Obesity and liver decompensation","volume":"14","author":"Ahn","year":"2019","journal-title":"Clinical Liver Disease"},{"key":"10.1016\/j.clnesp.2023.09.927_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1665-2681(19)31805-8","article-title":"Hepatogenous diabetes. Current views of an ancient problem","volume":"8","author":"Garc\u00eda-Compean","year":"2009","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib14","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1007\/s10620-016-4261-8","article-title":"Diabetes is associated with clinical decompensation events in patients with cirrhosis","volume":"61","author":"Liu","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clnesp.2023.09.927_bib15","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/003655201750313289","article-title":"Cardiovascular dysfunction in cirrhosis: pathophysiological evidence of a cirrhotic cardiomyopathy","volume":"36","author":"M\u00f8ller","year":"2001","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib16","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/hep.31608","article-title":"Hepatic fibrosis associates with multiple cardiometabolic disease risk factors: the Framingham heart study","volume":"73","author":"Long","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.clnesp.2023.09.927_bib17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/labinvest.2014.11","article-title":"Metabolically induced liver inflammation leads to NASH and differs from LPS-or IL-1\u03b2-induced chronic inflammation","volume":"94","author":"Liang","year":"2014","journal-title":"Lab Invest"},{"key":"10.1016\/j.clnesp.2023.09.927_bib18","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/joim.12540","article-title":"Adipose tissue regulates insulin sensitivity: role of adipogenesis, de novo lipogenesis and novel lipids","volume":"280","author":"Smith","year":"2016","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.clnesp.2023.09.927_bib19","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1111\/liv.13459","article-title":"Cirrhosis is a risk factor for atrial fibrillation: a nationwide, population-based study","volume":"37","author":"Lee","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.clnesp.2023.09.927_bib20","first-page":"38","article-title":"Glykosurie und Diabetes durch experimentelle Insulte und Krankheiten der Leber","volume":"7","author":"Naunyn","year":"1898","journal-title":"Der Diabetes Mellitus"},{"key":"10.1016\/j.clnesp.2023.09.927_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0168-8278(00)80065-3","article-title":"Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease","volume":"32","author":"Zein","year":"2000","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib22","doi-asserted-by":"crossref","first-page":"e3157","DOI":"10.1002\/dmrr.3157","article-title":"Prevalence of diabetes in liver cirrhosis: a systematic review and meta-analysis","volume":"35","author":"Lee","year":"2019","journal-title":"Diabetes Metabol Res Rev"},{"key":"10.1016\/j.clnesp.2023.09.927_bib23","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1665-2681(19)31030-0","article-title":"The prevalence and clinical characteristics of glucose metabolism disorders in patients with liver cirrhosis. A prospective study","volume":"11","author":"Garc\u00eda-Compe\u00e1n","year":"2012","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib24","first-page":"OC01","article-title":"Cirrhosis of liver and diabetes mellitus: the diabolic duo?","volume":"11","author":"Ramachandran","year":"2017","journal-title":"J\u00a0Clin Diagn Res: J Clin Diagn Res"},{"key":"10.1016\/j.clnesp.2023.09.927_bib25","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1440-1746.2002.02755.x","article-title":"Clinical implications of hepatogenous diabetes in liver cirrhosis","volume":"17","author":"Holstein","year":"2002","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/apt.15915","article-title":"Association between diabetes mellitus and hepatic encephalopathy in patients with cirrhosis","volume":"52","author":"Labenz","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clnesp.2023.09.927_bib27","doi-asserted-by":"crossref","first-page":"552","DOI":"10.4103\/ijem.IJEM_79_18","article-title":"Hepatogenous diabetes: an underestimated problem of liver cirrhosis","volume":"22","author":"Kumar","year":"2018","journal-title":"Indian J Endocrinol Metabolism"},{"key":"10.1016\/j.clnesp.2023.09.927_bib28","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.3748\/wjg.v19.i15.2298","article-title":"Dipeptidyl peptidase-4: a key player in chronic liver disease","volume":"19","author":"Itou","year":"2013","journal-title":"World J Gastroenterol: WJG"},{"key":"10.1016\/j.clnesp.2023.09.927_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11892-013-0453-1","article-title":"Advanced glycation end products (AGE) and diabetes: cause, effect, or both?","volume":"14","author":"Vlassara","year":"2014","journal-title":"Curr Diabetes Rep"},{"key":"10.1016\/j.clnesp.2023.09.927_bib30","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1172\/JCI35846","article-title":"Hypoxia-inducible factor-1\u03b1 regulates \u03b2 cell function in mouse and human islets","volume":"120","author":"Cheng","year":"2010","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.clnesp.2023.09.927_bib31","series-title":"Retracted: betatrophin: a hormone that controls pancreatic \u03b2 cell proliferation","author":"Yi","year":"2013"},{"key":"10.1016\/j.clnesp.2023.09.927_bib32","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v21.i37.10662","article-title":"Plasma betatrophin levels in patients with liver cirrhosis","volume":"21","author":"Arias-Loste","year":"2015","journal-title":"World J Gastroenterol: WJG"},{"key":"10.1016\/j.clnesp.2023.09.927_bib33","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/liv.13115","article-title":"Diabetes mellitus in patients with cirrhosis: clinical implications and management","volume":"36","author":"Elkrief","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.clnesp.2023.09.927_bib34","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.18466","article-title":"Association of type 2 diabetes with liver cirrhosis: a nationwide cohort study","volume":"8","author":"Hsieh","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.clnesp.2023.09.927_bib35","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/gut.51.6.870","article-title":"Mechanisms of hyperinsulinaemia in Child's disease grade B liver cirrhosis investigated in free living conditions","volume":"51","author":"Greco","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.clnesp.2023.09.927_bib36","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/01.mcg.0000190774.91875.d2","article-title":"Liver disease in patients with diabetes mellitus","volume":"40","author":"Harrison","year":"2006","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib37","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-133-8-200010170-00009","article-title":"Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States","volume":"133","author":"Mehta","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clnesp.2023.09.927_bib38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.diabet.2012.11.002","article-title":"Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside","volume":"39","author":"Gariani","year":"2013","journal-title":"Diabetes Metabol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib39","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1128\/JVI.00050-12","article-title":"Hepatitis C virus activates the mTOR\/S6K1 signaling pathway in inhibiting IRS-1 function for insulin resistance","volume":"86","author":"Bose","year":"2012","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib40","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/liv.13337","article-title":"Hepatogenous diabetes: is it time to separate it from type 2 diabetes?","volume":"37","author":"Orsi","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.clnesp.2023.09.927_bib41","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF01788899","article-title":"The haemochromatotic human pancreas: a quantitative immunohistochemical and ultrastructural study","volume":"30","author":"Rahier","year":"1987","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnesp.2023.09.927_bib42","first-page":"524","article-title":"Differential diagnosis of diabetes mellitus caused by liver cirrhosis and other type 2","volume":"12","author":"Kim","year":"2006","journal-title":"\ub300\ud55c\uac04\ud559\ud68c\uc9c0 \uc81c"},{"key":"10.1016\/j.clnesp.2023.09.927_bib43","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0168-8227(90)90093-9","article-title":"Alterations of glucose metabolism in chronic liver disease","volume":"8","author":"Blanco","year":"1990","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.clnesp.2023.09.927_bib44","doi-asserted-by":"crossref","first-page":"E526","DOI":"10.1503\/cmaj.092144","article-title":"Newly diagnosed diabetes mellitus as a risk factor for serious liver disease","volume":"182","author":"Porepa","year":"2010","journal-title":"CMAJ (Can Med Assoc J)"},{"key":"10.1016\/j.clnesp.2023.09.927_bib45","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/ajg.2014.132","article-title":"Mortality from chronic liver diseases in diabetes","volume":"109","author":"Zoppini","year":"2014","journal-title":"Official journal of the American College of Gastroenterology| ACG."},{"key":"10.1016\/j.clnesp.2023.09.927_bib46","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/liv.13241","article-title":"Association between diabetes mellitus and cirrhosis mortality: the Singapore Chinese Health Study","volume":"37","author":"Goh","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.clnesp.2023.09.927_bib47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature11450","article-title":"A\u00a0metagenome-wide association study of gut microbiota in type 2 diabetes","volume":"490","author":"Qin","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.clnesp.2023.09.927_bib48","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2796.1995.tb01194.x","article-title":"Gastrointestinal motility disorders in patients with diabetes mellitus","volume":"237","author":"Abrahamsson","year":"1995","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.clnesp.2023.09.927_bib49","first-page":"449","article-title":"Diabetes mellitus and decompensated cirrhosis: risk of hepatic encephalopathy in different age groups","volume":"5","author":"Butt","year":"2013","journal-title":"J\u00a0Diabetes"},{"key":"10.1016\/j.clnesp.2023.09.927_bib50","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/hep.27228","article-title":"Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C","volume":"60","author":"Elkrief","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.clnesp.2023.09.927_bib51","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jcma.2017.05.005","article-title":"Metformin reduces intrahepatic fibrosis and intrapulmonary shunts in biliary cirrhotic rats","volume":"80","author":"Ko","year":"2017","journal-title":"J\u00a0Chin Med Assoc"},{"key":"10.1016\/j.clnesp.2023.09.927_bib52","article-title":"Diabetes mellitus and risk of hepatic fibrosis\/cirrhosis","volume":"2019","author":"Li","year":"2019","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.clnesp.2023.09.927_bib53","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/jcp.22824","article-title":"AMP-activated protein kinase inhibits TGF-\u03b2-induced fibrogenic responses of hepatic stellate cells by targeting transcriptional coactivator p300","volume":"227","author":"Lim","year":"2012","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib54","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/jamainternmed.2016.9607","article-title":"Thiazolidinediones and advanced liver fibrosis in nonalcoholic steatohepatitis: a meta-analysis","volume":"177","author":"Musso","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.clnesp.2023.09.927_bib55","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3233\/CBM-170157","article-title":"Pioglitazone suppresses inflammation and fibrosis in nonalcoholic fatty liver disease by down-regulating PDGF and TIMP-2: evidence from in\u00a0vitro study","volume":"20","author":"Deng","year":"2017","journal-title":"Cancer Biomarkers"},{"key":"10.1016\/j.clnesp.2023.09.927_bib56","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12963-015-0065-x","article-title":"Population aging, macroeconomic changes, and global diabetes prevalence, 1990-2008","volume":"13","author":"Sudharsanan","year":"2015","journal-title":"Popul Health Metrics"},{"key":"10.1016\/j.clnesp.2023.09.927_bib57","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.amjmed.2007.03.025","article-title":"Impact of diabetes on the severity of liver disease","volume":"120","author":"Hickman","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.clnesp.2023.09.927_bib58","first-page":"72","article-title":"[An update on non-alcoholic fatty liver disease]","volume":"56","author":"M\u00e9ndez-S\u00e1nchez","year":"2004","journal-title":"Rev Invest Clin"},{"key":"10.1016\/j.clnesp.2023.09.927_bib59","series-title":"Diabetes, liver cancer, and cirrhosis: what next?","first-page":"1220","author":"Yki-J\u00e4rvinen","year":"2018"},{"issue":"Suppl 2","key":"10.1016\/j.clnesp.2023.09.927_bib60","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2036.2005.02590.x","article-title":"Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study","volume":"22","author":"Trombetta","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clnesp.2023.09.927_bib61","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2003.50095","article-title":"Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis","volume":"37","author":"Chalasani","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.clnesp.2023.09.927_bib62","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00042737-200411000-00003","article-title":"Mitochondrial injury in steatohepatitis","volume":"16","author":"Pessayre","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib63","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1053\/jhep.2001.29628","article-title":"Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients","volume":"34","author":"Crespo","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.clnesp.2023.09.927_bib64","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1053\/jhep.2001.28055","article-title":"High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis","volume":"34","author":"Paradis","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.clnesp.2023.09.927_bib65","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jhep.2008.12.017","article-title":"Insulin resistance predicts response to peginterferon-alpha\/ribavirin combination therapy in chronic hepatitis C patients","volume":"50","author":"Dai","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib66","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2006.05.013","article-title":"The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide","volume":"45","author":"Perz","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib67","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11906-004-0041-5","article-title":"Hypertension and liver disease","volume":"6","author":"Henriksen","year":"2004","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.clnesp.2023.09.927_bib68","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3748\/wjg.v12.i5.678","article-title":"Liver cirrhosis and arterial hypertension","volume":"12","author":"Henriksen","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib69","doi-asserted-by":"crossref","first-page":"G584","DOI":"10.1152\/ajpgi.2001.280.4.G584","article-title":"Arterial compliance in patients with cirrhosis: stroke volume-pulse pressure ratio as simplified index","volume":"280","author":"Henriksen","year":"2001","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib70","doi-asserted-by":"crossref","first-page":"G970","DOI":"10.1152\/ajpgi.00521.2002","article-title":"Central and noncentral blood volumes in cirrhosis: relationship to anthropometrics and gender","volume":"284","author":"M\u00f8ller","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib71","series-title":"Liver microvascular architecture: an insight into the pathophysiology of portal hypertension. Seminars in liver disease: \u00a9 1999","first-page":"359","author":"Ekataksin","year":"1999"},{"key":"10.1016\/j.clnesp.2023.09.927_bib72","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1053\/jhep.2002.31432","article-title":"The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough","volume":"35","author":"Wiest","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.clnesp.2023.09.927_bib73","first-page":"17","article-title":"Vasodilatation and hyperdynamic circulatory state in chronic liver disease","author":"Groszmann","year":"1994","journal-title":"Portal hypertension; pathophysiology and treatment"},{"key":"10.1016\/j.clnesp.2023.09.927_bib74","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/00365510152567059","article-title":"Vasoactive substances in the circulatory dysfunction of cirrhosis","volume":"61","author":"M\u00f8ller","year":"2001","journal-title":"Scand J Clin Lab Investig"},{"key":"10.1016\/j.clnesp.2023.09.927_bib75","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.dld.2007.01.009","article-title":"Essential hypertension and chronic viral hepatitis","volume":"39","author":"Parrilli","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clnesp.2023.09.927_bib76","series-title":"Lipids and HCV. Seminars in immunopathology","first-page":"87","author":"Bassendine","year":"2013"},{"key":"10.1016\/j.clnesp.2023.09.927_bib77","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.atherosclerosis.2013.10.030","article-title":"Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology","volume":"232","author":"Loria","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clnesp.2023.09.927_bib78","series-title":"HCV and host lipids: an intimate connection. Seminars in liver disease","first-page":"358","author":"Schaefer","year":"2013"},{"key":"10.1016\/j.clnesp.2023.09.927_bib79","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1590\/s0102-67202015000200012","article-title":"Lipid profile in cirrhotic patients and its relation to clinical outcome","volume":"28","author":"Boemeke","year":"2015","journal-title":"ABCD Arquivos Brasileiros de Cirurgia Digestiva (S\u00e3o Paulo)"},{"key":"10.1016\/j.clnesp.2023.09.927_bib80","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1590\/S0004-28032015000300011","article-title":"Lipid profile of cirrhotic patients and its association with prognostic scores: a cross-sectional study","volume":"52","author":"Bassani","year":"2015","journal-title":"Arq Gastroenterol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib81","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1080\/00325481.2021.1930560","article-title":"Association of lipid profile with decompensation, liver dysfunction, and mortality in patients with liver cirrhosis","volume":"133","author":"Feng","year":"2021","journal-title":"Postgrad Med"},{"key":"10.1016\/j.clnesp.2023.09.927_bib82","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3748\/wjg.v16.i11.1397","article-title":"Combined MELD and blood lipid level in evaluating the prognosis of decompensated cirrhosis","volume":"16","author":"Jiang","year":"2010","journal-title":"World J Gastroenterol: WJG"},{"key":"10.1016\/j.clnesp.2023.09.927_bib83","first-page":"14","article-title":"Comparative study of serum lipid profile between chronic hepatitis C Egyptian patients and normal controls and the effect of viral eradication on lipids profile","volume":"2","author":"Nashaat","year":"2010","journal-title":"Report and Opinion"},{"key":"10.1016\/j.clnesp.2023.09.927_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-7075-7-13","article-title":"Hepatic steatosis in hepatitis C is a storage disease due to HCV interaction with microsomal triglyceride transfer protein (MTP)","volume":"7","author":"Mirandola","year":"2010","journal-title":"Nutr Metabol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib85","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/j.1572-0241.2003.07402.x","article-title":"Hepatitis C virus\u2013associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis","volume":"98","author":"Petit","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib86","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S1542-3565(04)00622-6","article-title":"High-density lipoprotein cholesterol as an indicator of liver function and prognosis in noncholestatic cirrhotics","volume":"3","author":"Habib","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib87","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0026-0495(93)90166-L","article-title":"Lecithin-cholesterol acyltransferase and lipid transfer protein activities in liver disease","volume":"42","author":"Tahara","year":"1993","journal-title":"Metabolism"},{"key":"10.1016\/j.clnesp.2023.09.927_bib88","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7869\/tg.2012.67","article-title":"Nutritional status and prognosis in cirrhotic patients","volume":"33","author":"Sasidharan","year":"2012","journal-title":"Trop Gastroenterol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib89","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jneb.2019.06.022","article-title":"Krause's food & the nutrition care process","volume":"51","author":"Soldavini","year":"2019","journal-title":"J\u00a0Nutr Educ Behav"},{"key":"10.1016\/j.clnesp.2023.09.927_bib90","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.clnesp.2023.02.021","article-title":"Malnutrition and its association with the mortality in liver cirrhosis; a prospective nutritional assessment in two referral centers in Iran","volume":"54","author":"Pashayee-Khamene","year":"2023","journal-title":"Clinical Nutrition ESPEN"},{"key":"10.1016\/j.clnesp.2023.09.927_bib91","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s10620-015-4015-z","article-title":"The royal free hospital-nutritional prioritizing tool is an independent predictor of deterioration of liver function and survival in cirrhosis","volume":"61","author":"Borhofen","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clnesp.2023.09.927_bib92","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/jhn.12759","article-title":"Comparison between criteria for diagnosing malnutrition in patients with advanced chronic liver disease: GLIM group proposal versus different nutritional screening tools","volume":"33","author":"Boulhosa","year":"2020","journal-title":"J\u00a0Hum Nutr Diet"},{"key":"10.1016\/j.clnesp.2023.09.927_bib93","first-page":"914","article-title":"Predictors of mortality in patients on the waiting list for liver transplantation","volume":"28","author":"Ferreira","year":"2013","journal-title":"Nutr Hosp"},{"key":"10.1016\/j.clnesp.2023.09.927_bib94","first-page":"68","article-title":"Influence of hyponutrition on occurrence of complications and mortality among cirrhosis patients","volume":"23","author":"Rodr\u00edguez de Miranda","year":"2008","journal-title":"Nutr Hosp"},{"key":"10.1016\/j.clnesp.2023.09.927_bib95","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1097\/MEG.0b013e32834aa4bb","article-title":"Protein energy malnutrition predicts complications in liver cirrhosis","volume":"23","author":"Huisman","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib96","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/hep.26370","article-title":"The nutritional management of hepatic encephalopathy in patients with cirrhosis: international society for hepatic encephalopathy and nitrogen metabolism consensus","volume":"58","author":"Amodio","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.clnesp.2023.09.927_bib97","first-page":"2006","article-title":"Nutritional assessment of alcoholic liver cirrhotic patients treated in the liver Clinic of the Mexico's General Hospital","volume":"27","author":"Landa-Galv\u00e1n","year":"2012","journal-title":"Nutr Hosp"},{"key":"10.1016\/j.clnesp.2023.09.927_bib98","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/hep.29003","article-title":"A\u00a0practical approach to nutritional screening and assessment in cirrhosis","volume":"65","author":"Tandon","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.clnesp.2023.09.927_bib99","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/lt.23495","article-title":"Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value","volume":"18","author":"Tandon","year":"2012","journal-title":"Liver Transplant"},{"key":"10.1016\/j.clnesp.2023.09.927_bib100","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.cgh.2016.04.040","article-title":"A\u00a0model to identify sarcopenia in patients with cirrhosis","volume":"14","author":"Tandon","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib101","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/hep.21358","article-title":"Derivation and validation of a new global method for assessing nutritional status in patients with cirrhosis","volume":"44","author":"Morgan","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.clnesp.2023.09.927_bib102","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S2213-8587(20)30110-8","article-title":"Causes, consequences, and treatment of metabolically unhealthy fat distribution","volume":"8","author":"Stefan","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib103","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/apt.15571","article-title":"malnutrition\/sarcopenia and frailty in patients with cirrhosis","volume":"51","author":"Bunchorntavakul","year":"2020","journal-title":"Aliment Pharmacol Therapeut"},{"key":"10.1016\/j.clnesp.2023.09.927_bib104","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/jcsm.12039","article-title":"Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis","volume":"7","author":"Montano-Loza","year":"2016","journal-title":"J\u00a0cachexia, Sarcopenia Muscle"},{"key":"10.1016\/j.clnesp.2023.09.927_bib105","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0261-5614(02)00214-5","article-title":"Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials","volume":"22","author":"Kondrup","year":"2003","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnesp.2023.09.927_bib106","first-page":"536","article-title":"Nutritional risk assessment in patients with chronic liver disease","volume":"22","author":"Shi","year":"2014","journal-title":"Zhonghua gan Zang Bing za zhi= Zhonghua Ganzangbing Zazhi= Chinese Journal of Hepatology."},{"key":"10.1016\/j.clnesp.2023.09.927_bib107","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jcsm.12383","article-title":"GLIM criteria for the diagnosis of malnutrition\u2013a consensus report from the global clinical nutrition community","volume":"10","author":"Cederholm","year":"2019","journal-title":"J\u00a0cachexia, Sarcopenia Muscle"},{"key":"10.1016\/j.clnesp.2023.09.927_bib108","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1111\/ajt.15020","article-title":"Hepatic encephalopathy impacts the predictive value of the Fried Frailty Index","volume":"18","author":"Tapper","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.clnesp.2023.09.927_bib109","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jhep.2020.03.029","article-title":"Changes in frailty are associated with waitlist mortality in patients with cirrhosis","volume":"73","author":"Lai","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib110","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/hep.29219","article-title":"Development of a novel frailty index to predict mortality in patients with end-stage liver disease","volume":"66","author":"Lai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.clnesp.2023.09.927_bib111","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1097\/TP.0000000000001232","article-title":"A\u00a0comparison of muscle function, mass, and quality in liver transplant candidates: results from the functional assessment in liver transplantation (FrAILT) study","volume":"100","author":"Wang","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.clnesp.2023.09.927_bib112","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11011-012-9365-z","article-title":"Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study","volume":"28","author":"Merli","year":"2013","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.clnesp.2023.09.927_bib113","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.4254\/wjh.v14.i9.1694","article-title":"Nutritional assessment in patients with liver cirrhosis","volume":"14","author":"Ali","year":"2022","journal-title":"World J Hepatol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib114","first-page":"775","article-title":"Nutritional laboratory markers in malnutrition","volume":"8","author":"Keller","year":"2019","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.clnesp.2023.09.927_bib115","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.clinbiochem.2003.08.004","article-title":"Significance of elevated cobalamin (vitamin B12) levels in blood","volume":"36","author":"Ermens","year":"2003","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clnesp.2023.09.927_bib118","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jhep.2018.06.024","article-title":"EASL Clinical Practice Guidelines on nutrition in chronic liver disease","volume":"70","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib119","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4254\/wjh.v10.i10.685","article-title":"Nutritional support in chronic liver disease and cirrhotics","volume":"10","author":"Shergill","year":"2018","journal-title":"World J Hepatol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2022.04.021","article-title":"Overview of complications in cirrhosis","author":"Premkumar","year":"20221241150","journal-title":"J\u00a0Clinical Experimental Hepatol"},{"key":"10.1016\/j.clnesp.2023.09.927_bib121","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1016\/j.clnu.2020.09.001","article-title":"ESPEN practical guideline: clinical nutrition in liver disease","volume":"39","author":"Bischoff","year":"2020","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnesp.2023.09.927_bib122","first-page":"226","article-title":"Food groups intake of cirrhotic patients, comparison with the nutritional status and disease stage","volume":"12","author":"Pashayee-Khamene","year":"2019","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"10.1016\/j.clnesp.2023.09.927_bib123","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1017\/jns.2022.69","article-title":"Salt consumption and mortality risk in cirrhotic patients: results from a cohort study","volume":"11","author":"Pashayee-Khamene","year":"2022","journal-title":"J\u00a0Nutr Sci"},{"key":"10.1016\/j.clnesp.2023.09.927_bib124","first-page":"143","article-title":"Dietary protein sources and disease severity, malnutrition and anthropometric measurements in cirrhotic patients","volume":"12","author":"Pashayee-Khamene","year":"2019","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"10.1016\/j.clnesp.2023.09.927_bib125","first-page":"19","article-title":"Associations between Soy Intake and Disease Severity in Cirrhotic Patients: Results from a Cross-Sectional Study","volume":"15","author":"Movahedian","year":"2020","journal-title":"Iran J Nutr Sci Food Technol"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457723021575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457723021575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T01:05:39Z","timestamp":1719363939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457723021575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":123,"alternative-id":["S2405457723021575"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2023.09.927","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Keeping an eye on the nutrition: The importance of nutrition management on cardiometabolic risk factors in cirrhotic patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2023.09.927","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}